Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Glenmark Life Sciences Limited
GLSCurrent price
1 082.6 INR
+42.6 INR (+4.10%)
Last closed
1 059.75 INR
Company
www.glenmarklifesciences.com
ISIN
INE03Q201024
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
National Stock Exchange of India
Capitalization
134 363 452 694 INR
Yield for 12 month
+71.07 %
1Y
3Y
5Y
10Y
15Y
GLS
Glenmark Life Sciences Limited engages in the development, manufacture, and marketing of non-commoditized active pharmaceutical ingredients for various chronic therapeutic areas in India. The company offers various APIs, such as olmesartan, telmisartan, perindopril, atovaquone, solifenacin, mirabegron, sitagliptin, zonisamide, adapalene, and rosuvastatin. It also provides contract development and manufacturing services to a range of multinational corporations and specialty companies. The company's APIs are used in various therapeutic segments, including cardiovascular disease, central nervous system disorders, diabetes, gastrointestinal health, oncology, pain management, and anti-infectives. It also exports its products to Europe, North America, Latin America, Japan, and internationally. The company was incorporated in 2011 and is based in Mumbai, India. Glenmark Life Sciences Limited is a subsidiary of Nirma Limited. Address: OIA House, Mumbai, India, 400099
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
91 226.98 INRP/E ratio
31.8449Dividend Yield
–Current Year
+22 841 495 179 INR
Last Year
+21 621 055 289 INR
Current Quarter
+5 070 866 886 INR
Last Quarter
+5 888 571 774 INR
Current Year
+12 817 289 538 INR
Last Year
+11 476 020 207 INR
Current Quarter
+2 817 984 177 INR
Last Quarter
+2 296 900 720 INR
Key Figures GLS
1 year
3 years
5 years
10 years
EBITDA
6 029 649 553 INR
Operating Margin TTM
PE Ratio
31.8449
Return On Assets TTM
11.43 %
PEG Ratio
–
Return On Equity TTM
17.18 %
Wall Street Target Price
91 226.98 INR
Revenue TTM
22 057 994 770 INR
Book Value
207.28 INR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-14.9 %
Dividend Yield
–
Gross Profit TTM
11 148 265 978 INR
Earnings per share
34.43 INR
Diluted Eps TTM
34.43 INR
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
-20 %
Profit Margin
19.21 %
Dividend Analytics GLS
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
59 %Dividend History GLS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
17.10.2023
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
65.29 %
Last Split Date
–
Dividend Date
–
Stock Valuation GLS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
31.8449
Forward PE
–
Enterprise Value Revenue
6.1235
Price Sales TTM
6.0578
Enterprise Value EBITDA
20.5824
Price Book MRQ
5.2909
Financials GLS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GLS
For 52 weeks
620.45 INR
1 335.65 INR
50 Day MA
1 129.65 INR
Shares Short Prior Month
–
200 Day MA
922.22 INR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart